9 results
Dyspnea - Considerations with Malignancy
Directly Malignancy Related:
 - Lymphangitic spread to lung
 - Malignant pleural effusion
Dyspnea - Considerations ... effusion - Malignant ... Treatment Related ... #algorithm #differential ... #diagnosis #oncology
Fibrinous septations in Malignant Pleural Effusion (MPE) - Lung POCUS
 • can be triggered by thoracenteses
Fibrinous septations ... Effusion (MPE) ... - Lung POCUS • ... prospective e/o dyspnea ... #MPE #Lung #POCUS
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... pleural effusion ... goals of assessing lung ... #Effusions #MPE ... #Algorithm #Management
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... pleural effusion ... goals of assessing lung ... #Algorithm #Effusion ... #Malignant #Management
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
with CTD, drugs, malignancy ... History: cough, dyspnea ... Rare: pleural effusions ... Organizing Pneumonia Treatment ... #management
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and Pulmonary Thromboendarterectomy
Chronic Thromboembolic Pulmonary Hypertension
Definition: mean pulmonary-artery pressure > 25mmHg
Exercise intolerance, dyspnea ... 6 months after PE ... lung scanning showing ... Bypass Other Treatment ... #management
Pulmonary Renal Syndromes - OnePager Summary
Autoimmune ANCA vasculitis (AAV): GPA (granulomatous with polyangiitis), EGPA (eosinophilic granulomatosis
polyangiitis), MPA ... LVEF, pericardial effusion ... sparing of the lung ... glomerulonephritis (fibrinoid ... #management #treatment
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
starting amiodarone treatment ... exudative pleural effusions ... Dyspnea 3. ... embolism - Malignancy ... #management #Toxicology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
thickening or effusion ... and Arthritis Malignancy ... MALT Lymphoma • Lung ... Adenocarcinoma Treatment ... #Management